| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/04/2004 | WO2003070755A3 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier |
| 03/04/2004 | WO2003065044A3 Diagnostics and therapeutics for diseases associated with gpr72 |
| 03/04/2004 | WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/04/2004 | WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003043640A3 Treatment of major depressive disorder using glucocorticoid receptor antagonists |
| 03/04/2004 | WO2003042214A3 A2b adenosine receptor antagonists |
| 03/04/2004 | WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease |
| 03/04/2004 | WO2003032916A3 Organosulfur inhibitors of tyrosine phosphatases |
| 03/04/2004 | WO2003024928A3 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/04/2004 | WO2003014114A3 Substituted amine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/04/2004 | WO2003000268A8 Use of na+ channel blockers and aspirin in manufacturing drugs for producing analgesia synergistically in mammals |
| 03/04/2004 | WO2003000173A3 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | US20040044241 Novel succinate salt of O-desmethyl-venlafaxine |
| 03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040044084 Anesthetics; anticonvulsants; antiepileptic agents |
| 03/04/2004 | US20040044072 Substituted hydroxyethylamines |
| 03/04/2004 | US20040044061 Analgesics; side effect reduction |
| 03/04/2004 | US20040044056 Benzimidazole derivatives |
| 03/04/2004 | US20040044051 Cannabinoid receptor agonists |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 03/04/2004 | US20040044031 Controlling appetite; dietetics; sleep disorders |
| 03/04/2004 | US20040044026 3-Substituted quinuclidines and their use as nicotinic agonists |
| 03/04/2004 | US20040044022 Agent for treating neurodegenerative disorders |
| 03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 03/04/2004 | US20040044010 Central nervous system disorders; Alzheimer's disease; Parkinson's disease |
| 03/04/2004 | US20040044009 Drug abuse; cental nervous system disorders; cognition activators |
| 03/04/2004 | US20040044007 Pyschological and central nervous system diosrders; neurolptics; side effect reduction |
| 03/04/2004 | US20040044005 Nicotine addiction treatment |
| 03/04/2004 | US20040044003 Therapeutic agents useful for treating pain |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043996 Controlled release formulation of lamotrigine |
| 03/04/2004 | US20040043977 Alzheimer's disease |
| 03/04/2004 | US20040043968 Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treatment of urinary incontinence |
| 03/04/2004 | US20040043935 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043920 Chelate compound of metal and dithiocarbamate; therapy, diagnosis |
| 03/04/2004 | US20040043919 Method for the treatment of neurological and neuropsychological disorders |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/04/2004 | US20040043375 Regulation of human serine-threonine protein kinase |
| 03/04/2004 | US20040043171 Transdermal drug delivery |
| 03/04/2004 | US20040042964 Pharmaceutical composition which reduces or eliminates drug abuse potential |
| 03/04/2004 | DE10238724A1 New 6-alkyl-1,5-dihydro-4H-pyrazolo-(3,4-d)-pyrimidin-4-ones useful as selective phosphodiesterase 9A inhibitors for improving attention, concentration, learning and/or memory performance |
| 03/04/2004 | DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 03/04/2004 | CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system |
| 03/04/2004 | CA2496831A1 Treating alzheimers using delipidated protein particles |
| 03/04/2004 | CA2496234A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | CA2496197A1 5-substituted-2-arylpyrazines as modulators of crf receptors |
| 03/04/2004 | CA2495903A1 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | CA2495756A1 Acetophenone potentiators of metabotropic glutamate receptors |
| 03/04/2004 | CA2495597A1 Novel phenanthridines |
| 03/04/2004 | CA2495377A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 03/04/2004 | CA2495376A1 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 03/04/2004 | CA2494658A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome |
| 03/04/2004 | CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/03/2004 | EP1394178A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 03/03/2004 | EP1394175A1 Inhibitors of interleukin-1beta converting enzyme |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1394150A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 03/03/2004 | EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 03/03/2004 | EP1393747A1 Preventives/remedies for alzheimer's disease |
| 03/03/2004 | EP1393740A1 Novel remedies for neurodegenerative disease |
| 03/03/2004 | EP1393727A1 Remedial agent for myelopathic disease |
| 03/03/2004 | EP1393726A1 Compositions for improving mental concentration |
| 03/03/2004 | EP1393725A1 Compositions for ameliorating attention-deficient/hyperactivity disorder |
| 03/03/2004 | EP1393637A1 Agent for sustaining concentration and attentiveness and food and drink containing the agent |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392849A2 Yeast screens for agents affecting protein folding |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392827A2 Destruction of prions using vibriolysin or variants thereof |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392728A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 03/03/2004 | EP1392723A2 Medane genes and proteins |
| 03/03/2004 | EP1392713A2 Liver x receptor agonists |
| 03/03/2004 | EP1392700A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene |
| 03/03/2004 | EP1392699A1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/03/2004 | EP1392697A1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f]quinoline |
| 03/03/2004 | EP1392696A1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro 2,3-b]quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide |
| 03/03/2004 | EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 03/03/2004 | EP1392692A1 (oxo-pyrazolo 1,5a]pyrimidin-2-yl)alkyl-carboxamides |
| 03/03/2004 | EP1392689A1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 03/03/2004 | EP1392687A1 1,3,8-triazaspiro[4,5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 03/03/2004 | EP1392682A2 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/03/2004 | EP1392676A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 03/03/2004 | EP1392674A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392670A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 03/03/2004 | EP1392664A1 Epothilone derivatives |
| 03/03/2004 | EP1392663A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 03/03/2004 | EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
| 03/03/2004 | EP1392655A2 Potassium channel openers |